Cotización RARE Hoy | diciembre 04, 2023 | 07:50 PMBloomberg Línea
Ultragenyx Pharmaceutical Inc
RARE
41.24
USD
Evolución de la cotización:
Fecha | Hora | Precio |
---|---|---|
12/4/2023 | 2:30:00 PM | 40.38 |
12/4/2023 | 2:50:00 PM | 40.88 |
12/4/2023 | 2:55:00 PM | 40.53 |
12/4/2023 | 3:30:00 PM | 40.14 |
12/4/2023 | 4:05:00 PM | 40.02 |
12/4/2023 | 4:35:00 PM | 40.26 |
12/4/2023 | 4:40:00 PM | 40.395 |
12/4/2023 | 6:10:00 PM | 40.81 |
12/4/2023 | 6:40:00 PM | 40.85 |
12/4/2023 | 6:45:00 PM | 40.98 |
Noticias de RARE
BlackRock Sees Investor Appetite for Brazilian, Mexican Assets on the Rise
Aitor Jauregui, head for Latin America at the world’s largest asset manager, told Bloomberg Línea that foreign investors' demand for climate and infrastructure-related assets is increasing
Guyana: An Economic Miracle or a Short-Term Mirage In Latin America?
The South American country’s economy is expected to see the region’s fastest growth following the discovery of huge oil reserves, but which presents a huge challenge for its government
Latin American Governments Slow to Adopt New Technology, SAP Says
Cristina Palmaka, president of SAP for Latin America and the Caribbean, says the majority of the region’s countries have not successfully implemented technologies to enhance savings and cost efficiency
IMF Faces Growing Challenges in Dealing with Argentina’s Ongoing Economic Crisis
The IMF’s $43 billion Argentina problem is about to get worse due to ongoing economic challenges, political uncertainty, and geopolitical considerations
Mercados
Mercados
“Diciembre será difícil para acciones”: Wilson, de Morgan Stanley
El índice de referencia S&P 500 avanzó alrededor de 9% el mes pasado. Eso ha dejado al índice en territorio de sobrecompra, un nivel técnico que generalmente se considera precursor de una liquidación